The pulmonary hypertension drug market is experiencing strong growth as healthcare systems worldwide prioritize early diagnosis, improved treatment pathways, and access to advanced therapies. Pulmonary hypertension (PH) is a progressive and life-threatening condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure if untreated....